Filing Details
- Accession Number:
- 0001209191-22-044659
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-05 19:12:25
- Reporting Period:
- 2022-08-04
- Accepted Time:
- 2022-08-05 19:12:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649094 | Vaxcyte Inc. | PCVX | Biological Products, (No Disgnostic Substances) (2836) | 464233385 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1813800 | Jeff Fairman | C/O Vaxcyte, Inc. 825 Industrial Road, Ste. 300 San Carlos CA 94070 | Vp, Research | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-08-04 | 10,000 | $25.50 | 311,227 | No | 4 | S | Indirect | By Fairman Family Trust |
| Common Stock | Disposition | 2022-08-05 | 5,000 | $25.70 | 306,227 | No | 4 | S | Indirect | By Fairman Family Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Fairman Family Trust |
| No | 4 | S | Indirect | By Fairman Family Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 17,662 | Direct | |
| Common Stock | 50,000 | Indirect | By AF 2020 Irrevocable Trust |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- The price reported is a weighted-average price. The shares were sold at prices ranging from $25.50 to $26.035. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
